Dabrafenib,Trametinib
Novartis
['trametinib', 'roar', 'dabrafenib']
the #oncoalerttoptweet day2 of #aacr23
tweet by our faculty roar
this practice changing tissue agnostic study published in led to fda approval of dabrafenib+ trametinib in braf v600+ cancers. best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨